Note: Ingredients listed on restricted chemical lists
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
>=5-<10
General Information
Version
6.13
Revision date
2023-09-30
Product name
Pembrolizumab Liquid Formulation
1.2.1 Relevant identified uses
Pharmaceutical
Emergency telephone
1-908-423-6000
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360D, H373
Hazard statements
Code
Statements
H360D
May damage the unborn child
Section 2
SECTION 2: Hazards identification
GHS Classification GHS Classification Reproductive toxicity Category 1B Specific target organ toxicity - repeated exposure (Oral) Category 2 (Immune system)
Signal word
Danger
Hazard statements
H360D May damage the unborn child. H373 May cause damage to organs (Immune system) through prolonged or repeated exposure if swallowed.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe mist or vapors. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Reproductive toxicity : Category 1B Specific target organ toxicity - : Category 2 (Immune system) repeated exposure (Oral)
